Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
+0.43 (0.89%)
Jul 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 48.22 - 49.54
52 week 44.87 - 66.89
Open 48.44
Vol / Avg. 126,131.00/183,753.00
Mkt cap 1.10B
P/E 49.13
Div/yield 0.11/0.90
EPS 0.99
Shares 22.54M
Beta 0.73
Inst. own 109%
Oct 22, 2015
Abaxis Inc Annual Shareholders Meeting (Estimated) - 1:00PM EDT - Add to calendar
Oct 19, 2015
Q2 2016 Abaxis Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 23, 2015
Q1 2016 Abaxis Inc Earnings Call
Jul 23, 2015
Q1 2016 Abaxis Inc Earnings Release
Jun 4, 2015
Abaxis Inc at Jefferies Global Healthcare Conference
May 27, 2015
Abaxis Inc at Stifel Dental & Veterinary Conference
May 12, 2015
Abaxis Inc at Bank of America Merrill Lynch Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin 13.18% 10.27%
Operating margin 20.01% 16.93%
EBITD margin - 21.12%
Return on average assets 10.59% 8.55%
Return on average equity 12.61% 10.05%
Employees 582 -
CDP Score - -


3240 Whipple Rd
UNION CITY, CA 94587-1217
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems that are used in a range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. The Company provides veterinary reference laboratory diagnostic and consulting services for veterinarians. The Company operates in two segments, including the medical market and the veterinary market. The medical market and the veterinary market are based on the diagnostic products sold and services provided by market and customer group. The Company’s product and service offerings include VetScan Point-of-Care Blood Chemistry Instruments, VetScan Profiles, VSpro Specialty Analyzers and Consumables, and i-STAT Instruments and Consumables. Abaxis Europe GmbH, the Company’s wholly owned subsidiary in Griesheim, Germany, markets, promotes and distributes diagnostic systems for medical and veterinary uses in the European market.

Officers and directors

Clinton H. Severson Chairman of the Board, Chief Executive Officer
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald Peter Wood President, Chief Operating Officer
Age: 62
Bio & Compensation  - Reuters
Alberto R. Santa Ines Chief Financial Officer, Vice President - Finance
Age: 67
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 61
Bio & Compensation  - Reuters
Ross Taylor Chief Financial Officer, Secretary
Bio & Compensation  - Reuters
Craig M. Tockman Vice President, Sales & Marketing – NAAH
Age: 54
Bio & Compensation  - Reuters
Achim Henkel Vice President - Marketing for Pacific Rim, Vice President - Government Affairs, Managing Director of Abaxis Europe GmbH
Age: 56
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 69
Bio & Compensation  - Reuters